Literature DB >> 192738

The relative amounts of the cytoplasmic RNA species in normal, transformed and senescent cultured cell lines.

L F Johnson, H T Abelson, S Penman, H Green.   

Abstract

We have examined the relative quantities of 18S and 28S rRNA, 4S RNA and poly (A) + mRNA in the following cultured cells: the mouse fibroblast lines 3T3 and 3T6 in the resting (contact inhibited) and growing (sparse) states, 3T3 clones transformed with SV40 (SV3T3) and with both SV40 and polyoma SV-Py 3T3), hamster lung fibrobalsts (v79), human cervical carcinoma cells (HeLa), and human diploid fibroblasts at early and late passage. The relative quantities of the RNA species were determined by labeling the cells to equilibrium with 32PO4 and measuring the amount of label in each RNA species. The ratio of mRNA to rRNA varied form 1.1% to 2.7% in the different cell lines, the more rapidly growing cell lines usually giving a higher ratio. In cells experiencing growth limitation either by contact inhibition or due to senescence, the ratio of mRNA to rRNA was about 30% lower than in the corresponding cells in the growing state. In most cell lines the ratio of 4S RNA to 18S rRNA was between 0.8 and 1.2, but in seescent fibroblasts, this ratio increased to greater than 1.7. Senescent fibroblasts also contained much more total RNA per unit of DNA than the same cells at early passage or than 3T6 or 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192738     DOI: 10.1002/jcp.1040900310

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  The rate of RNA degradation in human dental pulp reveals post-mortem interval.

Authors:  Viktor S Poór; Dénes Lukács; Tamás Nagy; Evelin Rácz; Katalin Sipos
Journal:  Int J Legal Med       Date:  2015-11-25       Impact factor: 2.686

2.  Myotonic dystrophy type 1 RNA crystal structures reveal heterogeneous 1 × 1 nucleotide UU internal loop conformations.

Authors:  Amit Kumar; HaJeung Park; Pengfei Fang; Raman Parkesh; Min Guo; Kendall W Nettles; Matthew D Disney
Journal:  Biochemistry       Date:  2011-10-20       Impact factor: 3.162

Review 3.  Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.

Authors:  Alicia J Angelbello; Jonathan L Chen; Jessica L Childs-Disney; Peiyuan Zhang; Zi-Fu Wang; Matthew D Disney
Journal:  Chem Rev       Date:  2018-01-11       Impact factor: 60.622

Review 4.  RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Authors:  Viachaslau Bernat; Matthew D Disney
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

5.  Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.

Authors:  Matthew D Disney; Alicia J Angelbello
Journal:  Acc Chem Res       Date:  2016-11-22       Impact factor: 22.384

6.  Precise small-molecule recognition of a toxic CUG RNA repeat expansion.

Authors:  Suzanne G Rzuczek; Lesley A Colgan; Yoshio Nakai; Michael D Cameron; Denis Furling; Ryohei Yasuda; Matthew D Disney
Journal:  Nat Chem Biol       Date:  2016-12-12       Impact factor: 15.040

7.  Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs.

Authors:  Matthew D Disney; Audrey M Winkelsas; Sai Pradeep Velagapudi; Mark Southern; Mohammad Fallahi; Jessica L Childs-Disney
Journal:  ACS Chem Biol       Date:  2016-04-20       Impact factor: 5.100

8.  Features of modularly assembled compounds that impart bioactivity against an RNA target.

Authors:  Suzanne G Rzuczek; Yu Gao; Zhen-Zhi Tang; Charles A Thornton; Thomas Kodadek; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

9.  How We Think about Targeting RNA with Small Molecules.

Authors:  Matthew G Costales; Jessica L Childs-Disney; Hafeez S Haniff; Matthew D Disney
Journal:  J Med Chem       Date:  2020-03-26       Impact factor: 7.446

10.  Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.

Authors:  S C Clifford; D J Thomas; D E Neal; J Lunec
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.